This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08463/identifier/chemspider/
n11http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08463/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08463/identifier/pubchem-compound/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08463/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08463/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08463
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08463 n11:DB08463
dcterms:title
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol
adms:identifier
n8:DB08463 n9:RC8 n10:8400205 n12:10224714 n13:99444934
n3:IUPAC-Name
n4:271B5A92-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5A98-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5A97-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5A94-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5A95-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5A96-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5A90-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5A91-363D-11E5-9242-09173F13E4C5 n4:271B5A8E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5A8F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5A9E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5A9F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5A99-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5A9A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5A9C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5A9B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5A9D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5AA4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5AA6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5AA7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5AA3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5AA2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5AA5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5A93-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5AA0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5AA1-363D-11E5-9242-09173F13E4C5